| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |